Propafenone Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

16 Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 5 EU WC, 2 KDMF, 15 NDC API, 7 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

98 Dossiers, 53 FDA Orange Book, 23 Europe, 12 Canada, 2 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 225MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 225MG, CAPSULE, EXTENDED RELEASE;ORAL - 325MG, CAPSULE, EXTENDED RELEASE;ORAL - 425MG

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 32 BASF, 25 Roquette, 15 Microlex e.U, 14 Seppic, 12 Sigachi Industries, 11 Corel Pharma Chem, 11 Gangwal Chemicals, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 Gangwal Healthcare, 7 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Actylis, 5 Ideal Cures Pvt Ltd, 5 SPI Pharma, 4 Prachin Chemical, 4 Nanjing Well Pharmaceutical, 4 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 4 ACG Worldwide, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Seqens, 2 Finar, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 Qualicaps, 1 Aeon Procare, 1 DKSH, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Nanjing Bold Chemical, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 42 Disintegrants & Superdisintegrants, 39 Direct Compression, 32 Controlled & Modified Release, 31 Granulation, 29 Solubilizers, 24 Thickeners and Stabilizers, 19 Lubricants & Glidants, 16 Film Formers & Plasticizers, 14 Co-Processed Excipients, 14 Taste Masking, 14 Topical, 12 Parenteral, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Emulsifying Agents, 6 API Stability Enhancers, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 26 Finished Drug Prices

MARKET PLACE

6 APIs, 3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 3 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

13 News

13 News

Approved Marketing Authorisations (MA) containing Propafenone Hydrochloride in Europe. Original Data : EMA Website

Propafenone Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

16 Suppliers

12 USDMF

4 CEP/COS

2 JDMF

5 EU WC

2 KDMF

15 NDC API

7 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

98 Dossiers

53 FDA Orange Book

23 Europe

12 Canada

2 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 225MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 225MG

CAPSULE, EXTENDED RELEASE;ORAL - 325MG

CAPSULE, EXTENDED RELEASE;ORAL - 425MG

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

32 BASF

25 Roquette

15 Microlex e.U

14 Seppic

12 Sigachi Industries

11 Corel Pharma Chem

11 Gangwal Chemicals

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Gangwal Healthcare

7 Boai NKY Pharmaceuticals Ltd

7 DFE Pharma

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Actylis

5 Ideal Cures Pvt Ltd

5 SPI Pharma

4 Prachin Chemical

4 Nanjing Well Pharmaceutical

4 Vasa Pharmachem

4 Ingredion Pharma Solutions

4 ACG Worldwide

4 Kima Chemical

4 Pharmatrans-Sanaq

3 The Dow Chemical Company

3 Ulanqab Kema New Material

2 Seqens

2 Finar

2 Jai Radhe Sales

2 Nomisma Healthcare

2 Qualicaps

1 Aeon Procare

1 DKSH

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Nanjing Bold Chemical

1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders

49 Coating Systems & Additives

42 Disintegrants & Superdisintegrants

39 Direct Compression

TABLET;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 225MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons